Company intelligence / Profile preview
Cellphire Therapeutics, Inc.
Rockville, Maryland, United Statescellphire.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Cellphire has two products in Phase 2 clinical trials: CLPH-511 (Cryopreserved Platelets/CPP) and CLPH-211 (Freeze-dried Platelet-derived Hemostat/FPH). The CRYPTICS Phase 2/3 clinical study for CLPH-511 was stopped early for efficacy following pre-planned interim analysis. In March 2025, CLPH-511 received Fast Track designation from the FDA for treatment of acute hemorrhage. A Phase 2 clinical trial of Thrombosomes (FPH) in Acute Aortic Dissections completed enrollment of 41 patients ahead of schedule in June 2024.
- Therapeutic areas
- CardiovascularRheumatologyOtherHematologyNeurology
- Modalities
- Platelet-derived therapiesStabilized cellular therapeuticsAllogeneic platelet-derived cellular therapeutics
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →03
Partnerships
Biomedical Advanced Research and Development Authority (BARDA)Defense Advanced Research Projects Agency (DARPA)United States Special Operations Command (USSOCOM)United States Army Medical Research Acquisition Activity (USAMRAA)Medical Technology Enterprise Consortium (MTEC)
Beyond the preview
Go deeper on Cellphire Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellphire Therapeutics, Inc..